The U.S. Food and Drug Administration said on Tuesday that it is investigating reports of two deaths due to acute liver ...

Sarepta Therapeutics Inc. (NASDAQ:SRPT) is one of the best mid cap growth stocks to invest in now. Earlier on June 4, Sarepta ...

Recent developments in U.S. domestic affairs include a legal victory for Anthropic in an AI training lawsuit, Treasury ...

Sarepta has issued a safety update regarding Elevidys (delandistrogene moxeparvovec-rokl) following a second reported case of acute liver failure resulting in death.

Stop dogs, foxes and other animals from attacking your chickens when they are free-ranging by building a dog proof outer fence. There's more info but essentially this video documents how I built my ...

The agency said it will evaluate whether further regulatory action is needed after investigating the deaths of two patients ...

Higher tariffs could begin raising inflation this summer, a period that will be key to Federal Reserve consideration of ...

Investing.com -- The U.S. Food and Drug Administration is investigating reports of two deaths linked to Sarepta Therapeutics (NASDAQ: SRPT )’ gene therapy Elevidys, the agency announced Tuesday. The ...